The use of FK 506 in new-onset type I diabetes in man.
作者信息
Carroll P B, Tzakis A G, Ricordi C, Rilo H R, Abu-Elmagd K, Murase N, Zeng Y J, Alejandro R, Mintz D, Starzl T E
机构信息
Department of Surgery, University of Pittsburgh Medical School, PA 15213.
出版信息
Transplant Proc. 1991 Dec;23(6):3351-3.
Abstract
摘要
相似文献
1
The use of FK 506 in new-onset type I diabetes in man.FK506在人类新发I型糖尿病中的应用。
Transplant Proc. 1991 Dec;23(6):3351-3.
2
Long-term insulin requirement after liver transplantation with FK 506 in American veterans.美国退伍军人肝移植后使用FK 506的长期胰岛素需求情况。
Transplant Proc. 1993 Feb;25(1 Pt 1):677-8.
3
FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication.儿童移植人群中与FK 506相关的糖尿病是一种罕见的并发症。
Transplant Proc. 1991 Dec;23(6):3171-2.
4
FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh.FK506：一种用于治疗自身免疫性疾病的新型免疫抑制剂。匹兹堡大学的理论依据及初步临床经验
Springer Semin Immunopathol. 1993;14(4):323-44. doi: 10.1007/BF00192307.
5
Human islet allotransplantation under FK 506.在使用FK506情况下的人胰岛同种异体移植。
Transplant Proc. 1991 Dec;23(6):3207.
6
Lipids following pancreas transplantation in recipients receiving FK 506.接受FK506的胰腺移植受者的脂质情况
Transplant Proc. 1995 Dec;27(6):2997.
7
Conversion of pancreas transplants to FK 506 from CsA.胰腺移植从环孢素A转换为他克莫司（FK 506）。
Transplant Proc. 1995 Dec;27(6):3032-3.
8
Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients.糖尿病作为小儿肾移植患者使用他克莫司（FK506）的并发症。
Pediatr Nephrol. 1996 Feb;10(1):64-6. doi: 10.1007/BF00863448.
9
Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients.胰岛-肾移植受者转换为基于他克莫司和西罗莫司的免疫抑制治疗后实现胰岛素非依赖。
Transplantation. 2003 Oct 15;76(7):1133-4. doi: 10.1097/01.TP.0000090394.71832.E5.
10
The immunosuppressant FK-506 prevents progression of diabetes in nonobese diabetic mice.免疫抑制剂FK-506可预防非肥胖糖尿病小鼠的糖尿病进展。
Clin Immunol Immunopathol. 1990 Nov;57(2):274-9. doi: 10.1016/0090-1229(90)90041-n.
本文引用的文献
1
Levamisole in insulin-dependent diabetes mellitus.左旋咪唑与胰岛素依赖型糖尿病
N Engl J Med. 1980 Oct 30;303(18):1065-6. doi: 10.1056/NEJM198010303031818.
2
Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children.血浆置换在儿童胰岛素依赖型糖尿病初始治疗中的应用
Br Med J (Clin Res Ed). 1983 Jan 15;286(6360):176-8. doi: 10.1136/bmj.286.6360.176.
3
Remissions in newly diagnosed type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapy.新诊断的1型（胰岛素依赖型）糖尿病的缓解：干扰素作为胰岛素治疗辅助药物的影响。
Diabetologia. 1984 Aug;27(2):193-7. doi: 10.1007/BF00273805.
4
Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.环孢素免疫抑制对近期发病的胰岛素依赖型糖尿病的影响。
Science. 1984 Mar 30;223(4643):1362-7. doi: 10.1126/science.6367043.
5
Insulin antibodies in insulin-dependent diabetics before insulin treatment.胰岛素依赖型糖尿病患者在胰岛素治疗前的胰岛素抗体。
Science. 1983 Dec 23;222(4630):1337-9. doi: 10.1126/science.6362005.
6
Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus.单卵三胞胎和双胞胎中最初患1型糖尿病情况不一致者的胰岛细胞抗体和β细胞功能。
N Engl J Med. 1983 Feb 10;308(6):322-5. doi: 10.1056/NEJM198302103080607.
7
Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus.I型（胰岛素依赖型）糖尿病存在较长糖尿病前期的证据。
Lancet. 1981;2(8260-61):1363-5. doi: 10.1016/s0140-6736(81)92795-1.
8
Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine.
Diabetes. 1985 Dec;34(12):1306-8. doi: 10.2337/diab.34.12.1306.
9
Insulin-dependent diabetes mellitus and autoimmunity: islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure.胰岛素依赖型糖尿病与自身免疫：胰岛细胞自身抗体、胰岛素自身抗体与β细胞功能衰竭。
N Engl J Med. 1985 Oct 3;313(14):893-4. doi: 10.1056/NEJM198510033131417.
10
First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion.1型糖尿病患者的一级亲属。胰岛细胞抗体与胰岛素分泌异常。
N Engl J Med. 1985 Aug 22;313(8):461-4. doi: 10.1056/NEJM198508223130801.
Zotero 插件